𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐫𝐨𝐭𝐞𝐢𝐧 𝐀 𝐑𝐞𝐬𝐢𝐧 𝐏𝐨𝐰𝐞𝐫𝐡𝐨𝐮𝐬𝐞𝐬: 𝐓𝐨𝐩 𝟓 𝐂𝐨𝐮𝐧𝐭𝐫𝐢𝐞𝐬 𝐃𝐫𝐢𝐯𝐢𝐧𝐠 𝐆𝐫𝐨𝐰𝐭𝐡
According to a recent research, Industry revenue for Protein A Resin is expected to rise to $4.2 billion by 2035 from $1.3 billion of 2023. U.S., Germany and Japan are the top 5 markets and combinely holds substantial demand share. The revenue growth of market players in these countries is expected to range between 7.2% and 10.4% annually for period 2024 to 2035.
Industry transition including transition to sustainable resin materials and increased adoption of automated chromatography systems, are transforming the supply chain of Protein A Resin market. The trend towards using friendly materials in producing resin is beneficial, for sustainable bio manufacturing.
𝐏𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐀𝐫𝐞𝐚𝐬
Immunoprecipitation: In the field of research scientists utilize Protein A resins during immunoprecipitation to extract proteins from intricate samples with companies like Bio RAd and Thermo Fisher Scientific offering tailored resins, for educational and research environments.
Protein-Protein Interaction Studies: Protein A resins play a role in examining how proteins interact with each other during early stage research studies and help reveal important information for confirming the effectiveness of potential treatments or therapies. Genescript and Repligen are among the companies that provide customized resins specifically designed for use, in research and developmental purposes.
𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐚𝐧𝐝 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬
The Protein A Resin market is characterized by intense competition, with a number of leading players such as Cytiva, Thermo Fisher Scientific, Merck KGaA, Repligen, Purolite, Bio-Rad, GenScript, Avantor, Tosoh Bioscience, Danaher, Takara Bio and Agilent Technologies. These players are pushing the boundaries of innovation & technological advancements and forging strategic partnerships to expand the existing reach of the market. Below table briefs about adopted market strategies by leading players.
